What's New
News
Wave Life Sciences Ends FTD/ALS Trial of WVE-004
Yesterday, Wave Life Sciences announced that it ended its FOCUS-C9 clinical trial for the drug WVE-004, which…
AFTD and Alector Discuss FTD Therapeutic Development
AFTD recently spoke with Alector Chief Medical Officer Gary Romano, MD, PhD, about his colleagues’ work to…
“Coming Together for Change”: AFTD Volunteers Gather Virtually
“Calling all AFTD volunteers!” Recently, the AFTD Volunteer and Events Departments co-hosted virtual gatherings for our AFTD…
2023 Hope Rising Benefit Raises Crucial Funds for AFTD’s Mission
(L-R: Hope Rising Benefit Co-Chair David Zaslav, AFTD CEO Susan L-J Dickinson, AFTD Board member Kristin Holloway,…
AFTD Now Offering CME Credits to Healthcare Professional Webinar Attendees
As part of an ongoing organizational effort to provide vital FTD education to healthcare professionals, AFTD held…
Spotlight on… Julie Kelly, AFTD Board of Directors
Growing up, Julie Kelly was like a third sister to her best friends, identical twins Cathy Pfeifer…
